v3.26.1
Statement of Changes in Equity - Veraxa Biotech Holding A G [Member] - CHF (SFr)
Subscribed Capital [Member]
Retained Earning [Member]
Total Equity [Member]
Ending balance, value at Dec. 31, 2025 SFr 100,000 SFr (26,856) SFr 73,144
Ending balance, shares at Dec. 31, 2025 100,000    
Balance, June 25, 2025 (inception) at Jun. 24, 2025
Beginning balance, shares at Jun. 24, 2025    
IfrsStatementLineItems [Line Items]      
Initial contribution of capital SFr 100,000 100,000
Initial contribution of capital, shares 100,000    
Net loss (26,856) (26,856)
Ending balance, value at Dec. 31, 2025 SFr 100,000 SFr (26,856) SFr 73,144
Ending balance, shares at Dec. 31, 2025 100,000